AFB C/S (Hairs for Mycobacterium Tuberculosis) at Chughtai Lab

AFB C/S (Hairs for Mycobacterium Tuberculosis) at Chughtai Lab

The AFB C/S (Hairs for Mycobacterium Tuberculosis) at Chughtai Lab is a highly specialized, state-of-the-art microbiological investigation designed to isolate, identify, and determine the drug susceptibility of Mycobacterium tuberculosis and non-tuberculous mycobacteria (NTM) from hair follicle specimens. While tuberculosis is primarily known as a pulmonary disease, extrapulmonary tuberculosis can manifest in various organ systems, including the skin and integumentary structures. Cutaneous tuberculosis and mycobacterial infections of the hair follicles (tuberculous folliculitis) are rare but clinically challenging conditions that require precise diagnostic confirmation. This test plays a critical role in dermatological diagnostics, allowing clinical teams to differentiate mycobacterial infections from other chronic inflammatory or infectious scalp conditions, such as deep fungal infections, severe bacterial folliculitis, or alopecia areata with secondary infection.

By utilizing advanced culture techniques, including both solid Lowenstein-Jensen (LJ) media and automated liquid culture systems like the Mycobacteria Growth Indicator Tube (MGIT), Chughtai Lab ensures the highest diagnostic sensitivity and specificity. The culture process is followed by comprehensive drug sensitivity testing (DST), which is essential for identifying drug-resistant strains, such as multidrug-resistant tuberculosis (MDR-TB). This ensures that patients receive targeted, evidence-based therapeutic regimens, minimizing the risk of treatment failure and preventing the spread of resistant organisms. The diagnostic value of this test lies in its ability to provide a definitive microbiological diagnosis, which is far more reliable than clinical observation alone, especially given the atypical presentation of mycobacterial infections of the hair and scalp.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure the accuracy of the AFB C/S (Hairs for Mycobacterium Tuberculosis) test and to prevent contamination of the specimen with normal skin flora or external contaminants. Patients must adhere to the following guidelines prior to sample collection:

• Avoid Topical Treatments: Do not apply any medicated creams, ointments, hair oils, or topical antibiotics to the scalp or affected hair follicles for at least 48 to 72 hours before the test.
• Hair Washing: Wash your hair with a mild, non-medicated shampoo 24 hours before the collection. Do not use medicated or anti-dandruff shampoos immediately before the procedure, as they may contain antimicrobial agents that inhibit mycobacterial growth.
• Antibiotic History: Inform the laboratory staff and your prescribing physician if you are currently taking or have recently completed a course of antibiotics or anti-tubercular therapy (ATT), as these medications can significantly affect culture results.
• No Fasting Required: There are no dietary restrictions or fasting requirements for this test; patients may eat and drink normally.

During the Procedure

The sample collection process is performed under strict aseptic conditions by trained healthcare professionals at Chughtai Lab to maintain specimen integrity and ensure patient comfort:

• Aseptic Preparation: The technician will clean the skin surrounding the affected hair follicles with an alcohol swab to minimize contamination from superficial skin bacteria.
• Specimen Collection: Using sterile forceps, the healthcare professional will carefully pluck 10 to 15 hair shafts from the root. It is essential to collect the hair follicle (the bulb at the base of the hair), as mycobacteria reside within the follicular tissue and root sheath rather than the hair shaft itself.
• Specimen Transport: The plucked hair follicles are immediately placed into a sterile container without any transport media or preservatives, which could inhibit the growth of the slow-growing mycobacteria.
• Duration and Sensation: The procedure takes approximately 5 to 10 minutes. Patients may experience a mild, brief plucking sensation, but the procedure is generally well-tolerated and does not require local anesthesia.
• Safety Protocols: All collection procedures follow strict biosafety measures to protect both the patient and the healthcare worker from potential aerosol transmission or cross-contamination.

When is an AFB C/S (Hairs for Mycobacterium Tuberculosis) Performed?

Suspected Cutaneous Tuberculosis of the Scalp

Physicians request this test when a patient presents with chronic, progressive lesions on the scalp that are highly suggestive of cutaneous tuberculosis, such as lupus vulgaris or tuberculosis verrucosa cutis. These conditions can directly involve the hair follicles, leading to localized scarring, hair loss, and tissue destruction. The culture helps confirm the presence of Mycobacterium tuberculosis within the follicular structures.

Chronic Non-Healing Scalp Lesions and Folliculitis

When a patient suffers from chronic folliculitis, pustules, or ulcerations on the scalp that fail to respond to standard antibacterial or antifungal therapies, a mycobacterial etiology must be considered. The AFB culture and sensitivity test is performed to rule out or confirm atypical mycobacterial infections or localized tuberculous folliculitis, allowing for appropriate targeted therapy.

Atypical Mycobacterial Infections

Atypical or non-tuberculous mycobacteria (NTM), such as Mycobacterium chelonae or Mycobacterium fortuitum, can infect hair follicles following minor trauma, cosmetic procedures, or exposure to contaminated water. This test is crucial for identifying these specific pathogens, as their treatment protocols differ significantly from those used for standard Mycobacterium tuberculosis infections.

Monitoring Response to Anti-Tubercular Therapy (ATT)

For patients already diagnosed with cutaneous or follicular tuberculosis, the test may be repeated during or after the course of treatment. This helps clinicians assess whether the therapy is effectively eradicating the bacteria or if there is persistent viable infection, which could indicate treatment failure or the development of drug resistance.

Diagnostic Workup in Immunocompromised Patients

Immunocompromised individuals, such as those living with HIV/AIDS, undergoing chemotherapy, or taking immunosuppressive medications, are at a significantly higher risk for extrapulmonary and atypical mycobacterial infections. In these patients, skin and hair follicle infections can present atypically, making the highly specific AFB C/S test an essential diagnostic tool.

What Does an AFB C/S (Hairs for Mycobacterium Tuberculosis) Detect?

The AFB C/S (Hairs for Mycobacterium Tuberculosis) test is capable of detecting a wide range of microbiological and clinical findings, including:

• Presence of Acid-Fast Bacilli (AFB) on initial microscopic examination.
• Absence of Acid-Fast Bacilli (AFB), indicating no immediate microscopic evidence of infection.
• Growth of Mycobacterium tuberculosis complex, confirming active tuberculosis infection.
• Growth of non-tuberculous mycobacteria (NTM), indicating an atypical mycobacterial infection.
• Isolation of Mycobacterium bovis, a member of the M. tuberculosis complex.
• Isolation of Mycobacterium avium-intracellulare complex (MAC).
• Detection of Mycobacterium chelonae, a rapid-growing atypical mycobacterium.
• Detection of Mycobacterium fortuitum, often associated with localized skin and hair infections.
• Detection of Mycobacterium abscessus, known for drug resistance.
• Sensitivity to Isoniazid (INH), a primary first-line anti-tubercular drug.
• Resistance to Isoniazid (INH), suggesting monoresistance or potential multidrug resistance.
• Sensitivity to Rifampicin (RIF), the cornerstone of short-course tubercular therapy.
• Resistance to Rifampicin (RIF), which is a critical marker for multidrug-resistant tuberculosis (MDR-TB).
• Sensitivity to Ethambutol (EMB), a first-line companion drug.
• Resistance to Ethambutol (EMB).
• Sensitivity to Pyrazinamide (PZA).
• Resistance to Pyrazinamide (PZA).
• Sensitivity to second-line injectable drugs (e.g., Amikacin, Kanamycin) in cases of drug resistance.
• Resistance to second-line injectables, indicating pre-extensively drug-resistant (pre-XDR) or XDR-TB.
• Sensitivity to fluoroquinolones (e.g., Moxifloxacin, Levofloxacin).
• Resistance to fluoroquinolones.
• Contamination with normal skin flora (e.g., Staphylococcus epidermidis), which may require a repeat sample.
• No growth of mycobacteria after the standard 6-to-8-week incubation period, indicating a negative culture.

Turnaround Time and Report Access at Chughtai Lab

Because mycobacteria are extremely slow-growing organisms, the culture process requires an extended incubation period. Preliminary smear results (microscopy) are often available within 24 to 48 hours. However, the final culture report can take between 3 to 6 weeks for liquid culture systems (such as MGIT) and up to 8 weeks for solid media (Lowenstein-Jensen) to confirm a negative result. If growth is detected, drug sensitivity testing (DST) requires an additional 1 to 2 weeks to complete.

Chughtai Lab provides convenient and secure access to diagnostic reports. Once the results are verified by a consultant pathologist, patients receive an SMS notification. Reports can be viewed, downloaded, and printed online through the official Chughtai Lab website or the dedicated Chughtai Lab mobile application. Physical copies of the reports can also be collected from any Chughtai Lab diagnostic center across Pakistan.

AFB C/S (Hairs for Mycobacterium Tuberculosis) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
AFB Smear Microscopy	No Acid-Fast Bacilli (AFB) observed	Acid-Fast Bacilli (AFB) detected under microscopy
Mycobacterial Culture (Solid/Liquid)	No growth of mycobacteria after 6–8 weeks	Growth of Mycobacterium tuberculosis complex or NTM
Isoniazid (INH) Susceptibility	Organism is sensitive to Isoniazid	Organism is resistant to Isoniazid
Rifampicin (RIF) Susceptibility	Organism is sensitive to Rifampicin	Organism is resistant to Rifampicin (indicates MDR-TB risk)
Ethambutol (EMB) Susceptibility	Organism is sensitive to Ethambutol	Organism is resistant to Ethambutol
Pyrazinamide (PZA) Susceptibility	Organism is sensitive to Pyrazinamide	Organism is resistant to Pyrazinamide
Fluoroquinolone Susceptibility	Organism is sensitive to fluoroquinolones	Organism is resistant to fluoroquinolones
Specimen Adequacy	Adequate sample containing intact hair follicles	Inadequate sample (hair shafts only, no roots present)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Chughtai Lab for AFB C/S (Hairs for Mycobacterium Tuberculosis)?

• Experienced Healthcare Professionals: Our team consists of highly qualified microbiologists, pathologists, and lab technologists specializing in infectious disease diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the sample collection and testing process.
• Quality Diagnostic Services: Chughtai Lab utilizes international-standard quality control measures to ensure the highest accuracy in all diagnostic testing.
• Professional Reporting: All culture and sensitivity reports are thoroughly reviewed and signed off by consultant pathologists.
• Modern Diagnostic Approach: We employ advanced automated liquid culture systems (MGIT) alongside traditional solid media to optimize detection rates.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, safe, and welcoming environment for all patients.
• Convenient Location: With a vast network of laboratories and collection centers across Pakistan, accessing our services is simple and convenient.
• Commitment to Accurate Diagnosis: We are dedicated to providing precise, evidence-based results to guide effective clinical decision-making.